Gregory A. Vidal
Impact in
- Oncology top 5%
- HER2/EGFR in Cancer Research
- Cancer Immunotherapy and Biomarkers
- Cancer survivorship and care
- PARP inhibition in cancer therapy
- Family Practice top 5%
Papers in
- Oncology 43
- Global Cancer Incidence and Screening 10
- Cancer survivorship and care 9
- HER2/EGFR in Cancer Research 8
-
- Advanced Breast Cancer Therapies 17
- Lung Cancer Treatments and Mutations 9
- Co-authors
- Luis Marrero (4 shared papers)Frank E. Jones (4 shared papers)Anjali Naresh (2 shared papers)Lee S. Schwartzberg (33 shared papers)Christopher C. Williams (1 shared paper)Matthew E. Burow (1 shared paper)Barbara S. Beckman (1 shared paper)Ilana Graetz (20 shared papers)
- Journals
- Journal of Clinical Oncology (14 papers)Cancer Research (9 papers)Clinical Breast Cancer (4 papers)JAMA Network Open (3 papers)Journal of Cancer Survivorship (3 papers)
- Partner nations
- United StatesUnited KingdomSpain
In The Last Decade
Gregory A. Vidal
65 papers receiving 1.3k citations
Peers
Comparison fields: 5 of 94
- Oncology 784
- Family Practice 53
- Cancer Research 179
- Immunology and Allergy 70
- Radiology, Nuclear Medicine and Imaging 198
Countries citing papers authored by Gregory A. Vidal
This map shows the geographic impact of Gregory A. Vidal's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gregory A. Vidal with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gregory A. Vidal more than expected).
Fields of papers citing papers by Gregory A. Vidal
This network shows the impact of papers produced by Gregory A. Vidal. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gregory A. Vidal. The network helps show where Gregory A. Vidal may publish in the future.
Co-authors
The 25 scholars most cited alongside Gregory A. Vidal, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 76 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2004 | 213 | |
| 2 | 2006 | 172 | |
| 3 | 2005 | 109 | |
| 4 | 2018 | 108 | |
| 5 | 2019 | 93 | |
| 6 | 2018 | 65 | |
| 7 | 2006 | 43 | |
| 8 | 2020 | 38 | |
| 9 | 2021 | 28 | |
| 10 | 2022 | 27 | |
| 11 | 2017 | 23 | |
| 12 | 2022 | 21 | |
| 13 | 2020 | 19 | |
| 14 | 2019 | 19 | |
| 15 | 2020 | 18 | |
| 16 | 2019 | 17 | |
| 17 | 2020 | 16 | |
| 18 | 2022 | 16 | |
| 19 | 2020 | 15 | |
| 20 | 2018 | 14 |
About Gregory A. Vidal
Gregory A. Vidal is a scholar working on Oncology, Pulmonary and Respiratory Medicine, Cancer Research, Molecular Biology and Family Practice, having authored 76 papers that have together received 1.3k indexed citations. Recurring topics across this work include Advanced Breast Cancer Therapies (17 papers), Medication Adherence and Compliance (10 papers), Breast Cancer Treatment Studies (10 papers), Global Cancer Incidence and Screening (10 papers), Cancer Genomics and Diagnostics (9 papers), Lung Cancer Treatments and Mutations (9 papers), Cancer survivorship and care (9 papers) and HER2/EGFR in Cancer Research (8 papers). The work is most often cited by research in Oncology (784 citations), Family Practice (53 citations), Cancer Research (179 citations), Immunology and Allergy (70 citations) and Radiology, Nuclear Medicine and Imaging (198 citations). Gregory A. Vidal has collaborated with scholars based in United States, United Kingdom and Spain. Frequent co-authors include Luis Marrero, Frank E. Jones, Anjali Naresh, Lee S. Schwartzberg, Christopher C. Williams, Matthew E. Burow, Barbara S. Beckman, Ilana Graetz, Janeane N. Anderson and Athena Starlard‐Davenport. Their work appears in journals such as Journal of Clinical Oncology, Cancer Research, Clinical Breast Cancer, JAMA Network Open and Journal of Cancer Survivorship.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.